# Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma

> **NCT02929693** · PHASE3 · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 198 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** gefitinib
- **DRUG:** Yiqi-yangyin-jiedu decoction
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02929693
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2019-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929693, "Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02929693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*